Smart dosing for IBD: could a dashboard beat standard care?
NCT ID NCT04835506
First seen Apr 22, 2026 · Last updated May 14, 2026 · Updated 4 times
Summary
This study tests whether using a computer dashboard (iDose) to guide infliximab dosing is more effective and safer than standard dosing for people with Crohn's disease or ulcerative colitis. About 124 adults and teens will be followed for a year to see if the dashboard approach helps achieve and maintain remission without steroids. The goal is to better control these chronic inflammatory bowel diseases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atrium Health Center for Digestive Health
Charlotte, North Carolina, 28204, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03766, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Lahey Hospital and Medical Center
Burlington, Massachusetts, 01805, United States
-
LifeSpan Brown University
Providence, Rhode Island, 02915, United States
-
London Health Sciences Centre - Children's Hospital
London, Canada
-
McGill University Health Centre (MUHC) Montreal General Hospital
Montreal, Canada
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Northwestern University
Evanston, Illinois, 60208, United States
-
Rockford GI
Rockford, Illinois, 61107, United States
-
University of Chicago Medicine
Chicago, Illinois, 60637, United States
-
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Utah
Salt Lake City, Utah, 84132, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 20500, United States
-
Weill Cornell Medical College
New York, New York, 10065, United States
-
Yale University School of Medicine
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.